Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03185702 · ClinicalTrials.gov registry record
UTHealth Turner Syndrome Research Registry
A clinical trial of Turner Syndrome, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT03185702: Recruiting study of Turner Syndrome, sponsored by The University of Texas Health Science Center, Houston.
NCT03185702 is a study of Turner Syndrome that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 200 participants, below the 505-participant average among 14 other Turner Syndrome trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03185702, a study of Turner Syndrome, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will conduct genetic comparisons between Turner Syndrome (TS) patients with and without Bicuspid Aortic Valve (BAV) to identify causative agents of BAV in people with TS. The investigators will correlate the patterns and prevalence of structural heart defects in TS women with emerging molecular data to identify patients who are at high risk for cardiovascular complications
Primary Outcome
Imaging data
Conditions Studied
Interventions
- GENETIC Research genetic tests
Study Locations (1)
Texas
- University of Texas Health Science Center Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-08-28 |
| Est. Completion | 2035-01-01 |
What NCT03185702 shows while recruiting
NCT03185702 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 505-participant average among 14 other Turner Syndrome trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Turner Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Research genetic tests is the first listed.
NCT03185702 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03185702 about?
NCT03185702 is a clinical study titled "UTHealth Turner Syndrome Research Registry". The investigators will conduct genetic comparisons between Turner Syndrome (TS) patients with and without Bicuspid Aortic Valve (BAV) to identify causative agents of BAV in people with TS. The investigators will correlate the patterns and prevalence of structural heart defects in TS women with emer...
What is the current status of trial NCT03185702?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2015-08-28. Estimated completion is 2035-01-01.
What conditions does trial NCT03185702 study?
This clinical trial studies the following conditions: Turner Syndrome.
What interventions are being tested in trial NCT03185702?
The interventions under investigation include: Research genetic tests (GENETIC).
Who is sponsoring clinical trial NCT03185702?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03185702 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Turner Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03185702's enrollment target sits among peer trials
200 4th of 14 higher than 10 of 14 other Turner Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Turner Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Natural History of Noncirrhotic Portal Hypertension
RECRUITING
-
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
RECRUITING · Phase 4
-
Vosoritide for Short Stature in Turner Syndrome
RECRUITING · Phase 2
-
Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
RECRUITING
-
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
RECRUITING · Phase 2
-
Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI